Patent ID: 8263748

Claim:
A lyophilized formulation of an anti-human IL-23p19 antibody, or antigen binding fragment thereof, comprising: a) said anti-human IL-23p19 antibody, or antigen binding fragment thereof; b) sodium citrate; c) polysorbate 80; and d) sucrose wherein the antibody, or antigen binding fragment thereof, comprises: i) a light chain comprising CDRL1, CDRL2 and CDRL3, wherein: CDRL1 comprises the sequence of SEQ ID NO:36; CDRL2 comprises the sequence of SEQ ID NO:41; and CDRL3 comprises the sequence of SEQ ID NO:46; and ii) a heavy chain comprising CDRH1, CDRH2 and CDRH3, wherein: CDRH1 comprises the sequence of SEQ ID NO:19; CDRH2 comprises a sequence selected from the group consisting of SEQ ID NOs:24-26; and CDRH3 comprises the sequence of SEQ ID NO:31.